SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-115441
Filing Date
2024-04-26
Accepted
2024-04-26 06:05:27
Documents
13
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A d717083ddef14a.htm DEF 14A 355091
2 GRAPHIC g717083dsp0046.jpg GRAPHIC 7545
3 GRAPHIC g717083dsp0047.jpg GRAPHIC 7859
4 GRAPHIC g717083dsp046a.jpg GRAPHIC 82351
5 GRAPHIC g717083dsp046b.jpg GRAPHIC 18089
6 GRAPHIC g717083dsp046c.jpg GRAPHIC 3600
7 GRAPHIC g717083dsp046d.jpg GRAPHIC 3047
8 GRAPHIC g717083dsp046e.jpg GRAPHIC 2956
9 GRAPHIC g717083dsp046f.jpg GRAPHIC 3600
10 GRAPHIC g717083dsp047a.jpg GRAPHIC 1237
11 GRAPHIC g717083dsp047b.jpg GRAPHIC 1520
12 GRAPHIC g717083g03i03.jpg GRAPHIC 32254
13 GRAPHIC g717083g03i05.jpg GRAPHIC 28837
  Complete submission text file 0001193125-24-115441.txt   623760
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39866 | Film No.: 24878406
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)